| The mutational constraint spectrum quantified from variation in 141,456 humans KJ Karczewski, LC Francioli, G Tiao, BB Cummings, J Alföldi, Q Wang, ... Nature 581 (7809), 434-443, 2020 | 6967 | 2020 |
| Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ... science 310 (5748), 644-648, 2005 | 4807 | 2005 |
| ONCOMINE: a cancer microarray database and integrated data-mining platform DR Rhodes, J Yu, K Shanker, N Deshpande, R Varambally, D Ghosh, ... Neoplasia 6 (1), 1-6, 2004 | 3848 | 2004 |
| The mutational landscape of lethal castration-resistant prostate cancer CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ... Nature 487 (7406), 239-243, 2012 | 2677 | 2012 |
| Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles DR Rhodes, S Kalyana-Sundaram, V Mahavisno, R Varambally, J Yu, ... Neoplasia 9 (2), 166-180, 2007 | 2249 | 2007 |
| Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes KJ Karczewski, LC Francioli, G Tiao, BB Cummings, J Alföldi, Q Wang, ... biorxiv, 531210, 2019 | 1159 | 2019 |
| Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression DR Rhodes, J Yu, K Shanker, N Deshpande, R Varambally, D Ghosh, ... Proceedings of the National Academy of Sciences 101 (25), 9309-9314, 2004 | 1146 | 2004 |
| Integrative molecular concept modeling of prostate cancer progression SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ... Nature genetics 39 (1), 41-51, 2007 | 1095 | 2007 |
| Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ... Cancer cell 8 (5), 393-406, 2005 | 890 | 2005 |
| A gene expression signature associated with “K-Ras addiction” reveals regulators of EMT and tumor cell survival A Singh, P Greninger, D Rhodes, L Koopman, S Violette, N Bardeesy, ... Cancer cell 15 (6), 489-500, 2009 | 868 | 2009 |
| Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer DR Rhodes, TR Barrette, MA Rubin, D Ghosh, AM Chinnaiyan Cancer research 62 (15), 4427-4433, 2002 | 839 | 2002 |
| Identification of targetable FGFR gene fusions in diverse cancers YM Wu, F Su, S Kalyana-Sundaram, N Khazanov, B Ateeq, X Cao, ... Cancer discovery 3 (6), 636-647, 2013 | 766 | 2013 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 712 | 2021 |
| TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer SA Tomlins, R Mehra, DR Rhodes, LR Smith, D Roulston, BE Helgeson, ... Cancer research 66 (7), 3396-3400, 2006 | 584 | 2006 |
| Probabilistic model of the human protein-protein interaction network DR Rhodes, SA Tomlins, S Varambally, V Mahavisno, T Barrette, ... Nature biotechnology 23 (8), 951-959, 2005 | 535 | 2005 |
| Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification M Takahashi, DR Rhodes, KA Furge, H Kanayama, S Kagawa, BB Haab, ... Proceedings of the National Academy of Sciences 98 (17), 9754-9759, 2001 | 463 | 2001 |
| Integrative analysis of the cancer transcriptome DR Rhodes, AM Chinnaiyan Nature genetics 37 (Suppl 6), S31-S37, 2005 | 436 | 2005 |
| Urine TMPRSS2: ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA SA Tomlins, SMJ Aubin, J Siddiqui, RJ Lonigro, L Sefton-Miller, S Miick, ... Science translational medicine 3 (94), 94ra72-94ra72, 2011 | 426 | 2011 |
| A polycomb repression signature in metastatic prostate cancer predicts cancer outcome J Yu, J Yu, DR Rhodes, SA Tomlins, X Cao, G Chen, R Mehra, X Wang, ... Cancer research 67 (22), 10657-10663, 2007 | 408 | 2007 |
| The role of SPINK1 in ETS rearrangement-negative prostate cancers SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ... Cancer cell 13 (6), 519-528, 2008 | 402 | 2008 |
